Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Item

http://www.wikidata.org/entity/Q37701881

Q37701881

about

Metastatic disease from uveal melanoma: treatment options and future prospects Uveal melanoma as a target for immune-therapy Ocular diseases: immunological and molecular mechanisms Adjuvant Therapy of Uveal Melanoma: Current Status MicroRNA dysregulation in uveal melanoma: a new player enters the game Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma Uveal melanoma: From diagnosis to treatment and the science in between.Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).Management of uveal melanoma: a consensus-based provincial clinical practice guideline Extracutaneous melanomas: a primer for the radiologist.Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.IgE-based immunotherapy of cancer: challenges and chances.Atypical Presentation: Metastatic Uveal Melanoma in a Young Patient without Visual Complaints.Role of Epigenetics in Uveal Melanoma A molecular revolution in uveal melanoma: implications for patient care and targeted therapy Systematic genomic and translational efficiency studies of uveal melanoma.Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.Biology of advanced uveal melanoma and next steps for clinical therapeutics.MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives The biology of uveal melanoma Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.Interleukin-2, Ipilimumab, and Anti-PD-1: Clinical Management and the Evolving Role of Immunotherapy for the Treatment of Patients With Metastatic Melanoma.Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.Choroid Melanoma Metastasis to Spine: A Rare Case Report.Update on Metastatic Uveal Melanoma: Progress and Challenges.Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.Targeted agents and immunotherapies: optimizing outcomes in melanoma.Ipilimumab in melanoma.What have we learned from cancer immunotherapy in the last 3 years?Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.

P2860

Q26738377-E4C13C79-3DB0-4CDE-A5AA-309F189EC6C4 Q26747519-EE0A7E9C-BD8F-4509-9B9C-07C884C92F88 Q26747534-B4A10F84-FB3C-4AE5-B863-B76C2A860382 Q26865325-8BF88A88-6665-4981-9311-EBD094860805 Q27026746-41017898-D1E9-4159-A4A6-F47E72908739 Q28543960-BEC0D1DD-927E-446A-AD1E-AFB2BC28C293 Q30251762-B99127CB-FEBF-4FF5-81B9-92F4CFFD8104 Q30384829-9009297B-BBC6-4470-998F-F80A59C7C67E Q30388575-705877CF-8F55-4D5D-BB6B-955C7E0570CE Q30397680-383C67AF-AF42-4B8E-ADEE-8D420C3DBB78 Q33440852-3212040C-FC0D-4289-8978-D5A6D75A51A7 Q33619979-183CD388-FE2D-47BC-905B-1E5851DFC2B9 Q33701061-60FB02AB-7A3C-4262-A93B-C7F1863AE631 Q33703270-6420BE17-E562-449E-B86E-C2A16FE83970 Q33717375-9455B9FE-1686-4294-BED1-ED29DE7917F5 Q33778295-925E4061-5387-4BC3-97D6-76A729044917 Q33839273-48582A81-5E7E-4BB4-9EFC-FA644271BE13 Q33902364-BD7F8E0A-1405-4AC8-A7DA-0C6F61767693 Q34671157-05CB6052-3CEF-461F-B8F9-C5DD9861EAF9 Q35079709-4714ED81-C7FB-4092-AAA0-4CE50E4CDF89 Q35626803-B1038161-7461-4617-930F-8DDD54B28EDE Q36064844-094AFBCB-5B09-4DDA-8197-58A7DD98E5CE Q36132702-188A9EBE-9000-4D8E-8E08-CE1E47F09929 Q36863359-5C8B66BF-8BA8-45A8-883D-2C658967B08E Q37091138-37546A73-734C-4C32-8179-4F6CAA48A2FF Q37091144-A6FD1FAA-3DDE-4AD6-8D9B-A6AE0E805D66 Q37482566-26FF1D42-DC9D-495D-A44B-EC68C8E127F9 Q37742632-B154557A-CEF1-49F8-ABED-EDB23119CD2A Q38377528-4EAE9A63-CFAA-4FFD-BF29-184CF1243CC8 Q38595251-2A5D1C94-A95E-4668-A649-EC6BADF5D6EB Q38689912-A6DD93D9-426F-49E2-AF8E-67A2A103E5CF Q38713958-EDE6ACAD-806F-48A6-9F69-5ABF3233348D Q38738122-DDDD2F45-76E8-4580-A1A9-BA491C4594AE Q38783505-B2487262-81D1-495A-91ED-7F5C96698A3D Q38783820-E04862DD-1141-481A-9F55-0A0E74F41C68 Q38798084-E51C73AC-B1D5-42F8-9278-2FD32B8E5ABC Q38856722-F9FE0B5A-4E74-4765-9910-B0F64A7E8AD8 Q38893697-6B3B7897-39F1-4028-BFA5-CBBAB1653A0A Q40065733-6FE65CCF-239C-4D94-91D9-DBB9796966E4 Q40251215-110F2B02-AEA8-4350-9D1A-E72724992B79

P2860

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Item

http://www.wikidata.org/entity/Q37701881

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs